Multiplikator Forward P/S: MannKind Corp. (MNKD)

Logo perusahaan publik MannKind Corp. (MNKD)

MannKind Corporation (MNKD) revenues are based on royalties from Tyvaso DPI and the sale of Afrezza. The GURU.Markets platform broadcasts the future P/S metric, where the 3.20 indicator determines the parameter status. Robotic packaging lines in sterile zones drive the company's growth. Innovative powder-form insulin eliminates injections for patients, offering a revolutionary pulmonary drug delivery system.

MNKD MannKind: Kapitalisasi marang prakiraan pendapatan ing interval 04.07.2022 - 15.11.2026

Rincian metrik lan analitis perusahaan MannKind Corporation (MNKD)

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:MNKD (MannKind Corporation)
Produk asli Afrezza

MannKind Corporation is scaling the inhalation drug delivery systems market by replacing traditional injections. The forward P/S ratio correlates the business's market value with expected future sales, measuring the premium for potential revenue growth. This metric allows for an assessment of how effectively innovations are capitalized amid liquidity inflows. By analyzing the projected P/S trend, an investor can timely detect the risk of asset overvaluation.

Analisis pesaing MannKind Corporation

Multiplikator Forward P/S HLN (Haleon PLC)|Multiplikator Forward P/S Kenvue Corp KVUE|Verona Pharma PLC - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep jyongbio.com|LGND: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan AMRX|Rasio rega marang prakiraan pendapatan Perrigo Company|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alvotech ALVO|Multiplikator Forward P/S LQDA|GLPG: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S ANIP (ANI Pharmaceuticals, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake Amphastar (AMPH)|PCRX: Multiplikator forward rega marang pendapatan|SPRY - Multiplikator Forward P/S|Theravance Biopharma, Inc. (TBPH) - Rasio rega marang prakiraan pendapatan|AQST (Aquestive Therapeutics) - Rasio rega marang prakiraan pendapatan|SCPH (scpharmaceuticals.com) - Multiplikator Forward P/S|TECX: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S EPRX (Eupraxia Pharmaceuticals)|Rega forward marang dodolan BHST|Invizyne Technologies - Multiplikator Forward P/S|oramed.com (ORMP) - Multiplikator forward rega marang pendapatan|ENTX (enterabio.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan HYFT|ABVC (ABVC BioPharma, Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S cumberlandpharma.com|Rasio rega marang prakiraan pendapatan Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prakiraan rega marang pendapatan|Multiplikator Forward P/S TELO (telomirpharma.com)|RANI - Multiplikator forward rega marang pendapatan|SNYR - Rasio rega marang prakiraan pendapatan|rallybio.com - Rasio rega marang pendapatan sing dikarepake|LEXX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pulmatrix Inc|PTHL (Pheton Holdings) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aptorum Group Limited APM|Rasio rega marang prakiraan pendapatan Lyra Therapeutics (LYRA)|Multiplikator forward rega marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang prakiraan pendapatan tnfpharma.com TNFA|Rega forward marang dodolan YCBD|PainReform Ltd - Multiplikator Forward P/S|Altamira Therapeutics Ltd (CYTO) - Multiplikator forward rega marang pendapatan|lipella.com (LIPO) - Rasio rega marang prakiraan pendapatan|OptiNose (OPTN) - Multiplikator Forward P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Petros Pharmaceuticals, Inc. (PTPI)|Multiplikator Forward P/S Qilian International Corp (QLI)|ACELYRIN, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S tffpharma.com TFFP